Exploring Central Sensitization in Pregnant Women
In the Joints or in the Brain? Exploring Central Sensitization in Pregnant Women and Its Role in Pain, Physical Activity, Functioning and Health Following Pregnancy
Göteborg University
144 participants
Aug 15, 2023
OBSERVATIONAL
Conditions
Summary
Pelvic Girdle Pain (PGP) is reported by 50% of pregnant women and up to 11 years after pregnancy, 10% of women have persistent and per definition chronic PGP. Central (nervous system) sensitization that elicits pain hypersensitivity, may be one explanation. The overall aim of this study is to explore features of central sensitization in pregnant women and its predictive ability on physical activity, functioning and health in women with PGP. Measurements of central sensitization will be done on two study groups, pregnant women with PGP and healthy controls. To identify women at risk to develop chronic pain in relation to a common pain experience ie PGP in pregnancy, may help us understand if central sensitization early in life explains why women develop chronic pain.
Eligibility
Inclusion Criteria5
- pregnant (first time pregnant or previous experience of pregnancy)
- years of age or older
- have a single foetus pregnancy
- be in gestational weeks 20-30
- able to read and understand Swedish or English
Exclusion Criteria5
- no history of a fracture or malignant disease in the back, pelvis, pelvic floor or hips
- no systemic disease of the musculoskeletal or the nervous system
- no diseases such as gestational diabetes or diabetes type 1 and 2, hypertension
- no obstetric complications
- no contradiction for tests.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05507853